Valbiotis Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8.68	11.58	25.02	20.83	21.82
Cash & Short-Term Investments	8.68	11.58	25.02	20.83	21.82
Cash Growth	-25.08%	-53.71%	20.11%	-4.54%	49.60%
Accounts Receivable	0.78	3.21	4.63	2.94	2.95
Inventory	2.47	2.09	1.01	0.53	0.42
Total Current Assets	11.92	16.87	30.65	24.3	25.19
Net Property, Plant & Equipment	1.18	1.47	1.41	1.82	2.22
Other Intangible Assets	1.2	1.11	1.08	0.94	0.96
Long-Term Investments	0.09	0.16	0.17	0.15	0.17
Other Long-Term Assets	-	-	0	0	-
Total Assets	14.39	19.61	33.31	27.22	28.54
Accounts Payable	2.21	3.37	1.87	1.57	1.46
Accrued Expenses	-	-	1.29	1.09	0.73
Current Portion of Long-Term Debt	1.73	1.63	1.61	1.14	1.03
Current Portion of Leases	0.25	0.55	0.5	0.45	0.43
Unearned Revenue	-	-	3.51	3.86	4.29
Total Current Liabilities	4.18	5.55	8.77	8.11	7.94
Long-Term Debt	2.21	2.52	3.9	4.35	4.6
Long-Term Leases	0.91	1.02	0.88	1.23	1.53
Other Long-Term Liabilities	0.13	0.15	0.16	0.16	0.18
Total Long-Term Liabilities	3.24	3.69	4.93	5.75	6.31
Total Liabilities	7.43	9.24	13.71	13.86	14.25
Common Stock	2.37	1.58	1.58	1.24	0.97
Additional Paid-in Capital	6.16	1.25	18.23	37.1	32.33
Accumulated Other Comprehensive Income	7.85	17.56	7.16	-12.67	-10.33
Retained Earnings	-9.42	-10.03	-7.37	-12.31	-8.68
Shareholders' Equity	6.96	10.37	19.6	13.36	14.3
Total Liabilities & Equity	14.39	19.61	33.31	27.22	28.54
Total Debt	5.09	5.72	6.88	7.18	7.59
Net Cash (Debt)	3.59	5.86	18.14	13.65	14.23
Net Cash Growth	-38.82%	-67.69%	32.88%	-4.05%	87.89%
Net Cash Per Share	0.18	0.37	1.46	1.35	1.55
Book Value	6.96	10.37	19.6	13.36	14.3
Book Value Per Share	0.35	0.66	1.57	1.32	1.56
Tangible Book Value	5.76	9.26	18.52	12.41	13.34
Tangible Book Value Per Share	0.29	0.59	1.49	1.23	1.46